Related Experiment Videos
[Prognostic value of neuroendocrine activation after acute myocardial infarction]
1Medisinsk Avdeling, Sentralsjukehuset i Rogaland, Universitetet i Bergen.
Insights
Neurohumoral activation after acute myocardial infarction (AMI) is linked to poorer survival. Measuring neurohormone levels may offer independent prognostic insights for AMI patients, but clinical use needs further study.
Area of Science:
- Cardiology
- Neuroendocrinology
Context:
- Acute myocardial infarction (AMI) triggers complex neurohumoral responses.
- Elevated neurohumoral activation correlates with adverse outcomes and reduced survival post-AMI.
Purpose:
- To evaluate the prognostic value of neurohumoral assessment in acute myocardial infarction.
- To determine if neurohormone concentrations provide independent predictive information beyond established clinical factors.
Summary:
- Neurohumoral activation is a significant factor in acute myocardial infarction (AMI).
- While its predictive power can diminish with multivariate adjustments, circulating neurohormone levels show potential for independent prognostic information in AMI.
- Further research is needed to establish the clinical utility of neurohumoral assessment for risk stratification and guiding therapeutic interventions in AMI patients.
Impact:
- Potential to refine risk stratification models for acute myocardial infarction.
- May identify specific patient subgroups who could benefit from targeted neurohumoral therapies.
- Highlights the importance of understanding the neurohumoral system's role in cardiovascular disease prognosis.
Abstract:
Complex neurohumoral activation is associated with acute myocardial infarction. Either as a cause of adverse events or as a marker of haemodynamic status, augmented neurohumoral activation is associated with decreased short- and long-term survival. Although the predictive value of neurohumoral assessment is generally reduced after adjustment for demographic, clinical and haemodynamic variables in multivariate models, recent data suggest that determination of circulating neurohormone concentrations may provide significant, independent prognostic information in cases of acute myocardial infarction. The clinical usefulness of neurohumoral determination as a risk stratification tool and as a method of identifying patients who might benefit from therapeutic intervention remains to be established.